// App-Quantinova.ai

OP0012 : TNF INHIBITORS ARE ASSOCIATED WITH A REDUCED RISK OF VENOUS THROMBOEMBOLISM COMPARED TO CSDMARDS IN RA PATIENTS

Researchers

Presenter

  • M. Schaefer

Principal Investigators

  • M. Schneider

  • A. Graessler

  • W. Ochs

  • A. Zink

  • A. Strangfeld

Medical Centers

  • German Rheumatism Research Centre, Berlin, Germany

  • Scientific Advisory Board Dusseldorf, Duesseldorf, Germany

  • Rheumatologist, Berlin, Germany

  • Rheumatologist, Bayreuth, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline (GSK)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved